Surgery combined with oncological treatments in liver metastases from colorectal cancer

Scandinavian Journal of Surgery

Volumn 100, Issue 1, 2011, Pages 35-41

  Isoniemi, H ^a,b   Osterlund P ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Adjuvant chemotherapy; Colorectal cancer; Liver metastases; Liver resection; Liver surgery; Neoadjuvant chemotherapy; Thermoablation

Indexed keywords

EID: 79952954085     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749691110000107     Document Type: Article

References (66)

1. Kopetz S, Chang GJ, Overman MJ, et al: Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009;27:3677-3683
2. Folprecht G, Grothey A, Alberts S, et al: Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005;16:1311-1319
3. G arden OJ, Rees M, Poston GJ, et al: Guidelines for resection of colorectal cancer liver metastases. Gut. 2006; 55 Supp l3: iii1-8
4. Folprecht G, Gruenberger T, Bechstein WO, et al: Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 2010 Jan; 11: 38-47
5. Elias D, Ouellet JF, Bellon N, et al: Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 2003;90:567-574
6. Carpizo DR, Are C, Jarnagin W, et al: Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Ann Surg Oncol 2009;6:2138-2146
7. Shah SA, Haddad R, Al-Sukhni W, et al: Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 2006;202:468-475
8. Mise Y, Imamura H, Hashimoto T, et al: Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases. Ann Surg 2010;251:902-909
9. Thelen A, Jonas S, Benckert C, et al: Repeat liver resection for recurrent liver metastases from colorectal cancer. Eur J Surg Oncol 2007;33:324-328
10. Jonas S, Thelen A, Benckert C, et al: Extended resections of liver metastases from colorectal cancer. World J Surg 2007;31: 511-521
11. N ordlinger B, Sorbye H, Glimelius B, et al: Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008;371:1007-1016
12. Ruers TJM, Wiering B, van der Sijp JRM, et al: Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study. J Nucl Med 2009; 50:1036-1041
13. Uchiyama K, Ueno M, Ozawa S, et al: Combined use of contrast-enhanced intraoperative ultrasonography and a fluorescence navigation system for identifying hepatic metastases. World J Surg 2010;34:2953-2959
14. Smyrniotis V, Kostopanagiotou G, Theodoraki K, et al: The role of central venous pressure and type of vascular control in blood loss during major liver resections. Am J Surg 2004;187: 398-402
15. Wang W-D, Liang L-J, Huang X-Q, et al: Low central venous pressure reduces blood loss in hepatectomy. World J Gastroenterol 2006;12:935-539
16. Fortner JG, Blumgart LH: A historic perspective of liver surgery for tumors at the end of the millennium. J Am Coll Surg 2001;193:210-222
17. Pamecha V, Gurusamy KS, Sharma D, et al: Techniques for liver parenchymal transection: a meta-analysis of randomized controlled trials. HBP (Oxford) 2007;11:275-281
18. Takayama T, Makuuchi M, Kubota K, et al: Randomized comparison of ultrasonic vs clamp transection of the liver. Arch Surg 2001;136:922-928
19. Poon RT: Current techniques of liver transection. HPB (Oxford) 2007;9:166-173
20. Capussotti L, Muratore A, Ferrero A, et al: Randomized clinical trial of liver resection with and without hepatic pedicle clamping. Br J Surg 2006;93:685-689
21. Makuuchi M, Thai BL, Takayasu K, et al: Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990;107: 521-527
22. Abdalla EK, Hicks ME, Vauthey JN: Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001;88: 165-175.
23. Abdalla EK: Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome. J Surg Oncol 2010;102:960-967
24. Hemming AW, Reed AI, Howard RJ, et al: Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003; 237:686-691
25. Pamecha V, Nedjat-Shokouhi B, Gurusamy K, et al: Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases. Dig Surg 2008;25:387-393
26. de Jong MC, van Vledder MG, Ribero D, et al: Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis. J Gastrointest Surg 2011;15(2):336-344
27. Minagawa M, Makuuchi M, Torzilli G, et al: Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000;231:487-499
28. Pawlik TM, Vauthey J-N: Surgical margins during hepatic surgery for colorectal liver metastases: complete resection not millimeters defines outcome. Ann Surg Oncol 2008;15:677-679
29. Figueras J, Burdio F, Ramos E, et al: Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol 2007;18:1190-1195
30. Gomez D, Cameron IC: Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise? HPB (Oxford) 2010;12:227-238
31. Fong Y, Fortner J, Sun RL, et al: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309-318
32. A dam R, Pascal G, Castaing D, et al: Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240:1052-1061
33. Neumann UP, Thelen A, Rocken C, et al: Nonresponse to preoperative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases. Surgery 2009;146:52-59
34. Blazer DG, 3rd, Kishi Y, Maru DM, et al: Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 2008; 26:5344-5351
35. Brouquet A, Mortenson MM, Vauthey J-N, et al: Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 2010;210:934-941
36. Tanaka K, Shimada H, Matsuo K, et al: Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 2004;136:650-659
37. Kaibori M, Iwamoto S, Ishizaki M, et al: Timing of resection for synchronous liver metastases from colorectal cancer. Dig Dis Sciences 2010;55:3262-3270
38. Bismuth H, Adam R, Levi F, et al: Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-520
39. Adam R: Neoadjuvant treatment for liver metastases of colorectal cancer. European Oncological Disease 2007;3:77-79
40. Khan AZ, Morris-Stiff G, Makuuchi M: Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg 2009;16:137-144
41. Pawlik TM, Olino K, Gleisner AL, et al: Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 2007;11: 860-868
42. Karoui M, Penna C, Amin-Hashem M, et al: Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1-7
43. Tamandl D, Gruenberger B, Klinger M, et al: Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study. Ann Surg 2010;252:124-130
44. Ribero D, Wang H, Donadon M, et al: Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorec tal liver metastases. Cancer 2007;110:2761-2767
45. Gruenberger B, Tamandl D, Schueller J, et al: Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol 2008;26:1830-1835
46. Wong R, Saffery C, Barbachano Y, et al: BOXER: A multicentre phase II trial of capecitabine and oxaliplatin plus bevacizumab as neoadjuvant treatment for patients with liver-only metastases from colorectal cancer unsuitable for upfront resection European Journal of Cancer Supplements 2009;7:344
47. Reddy SK, Morse MA, Hurwitz HI, et al: Addition of bevacizumab to irinotecan-and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases. J Am Coll Surg 2008;206:96-106
48. Mahfud M, Breitenstein S, El-Badry AM, et al: Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study. World J Surg 2010;34:92-100
49. Van Cutsem EJ, Oliveira J: Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and followup. Ann Oncol 2008;19:ii33-34
50. Nordlinger B, Van Cutsem E, Gruenberger T, et al: Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol 2009;20:985-992
51. Benoist S, Brouquet A, Penna C, et al: Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 2006;24:3939-3945
52. Elias D, Youssef O, Sideris L, et al: Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol 2004;86:4-9
53. de Jong MC, Pulitano C, Ribero D, et al: Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 2009;250:440-448
54. Sobrero A, Guglielmi A: Current controversies in the adjuvant therapy of colon cancer. Ann Oncol 2004;15 Suppl 4:iv39-41
55. Power DG, Kemeny NE: Role of adjuvant therapy after resection of colorectal cancer liver metastases. J Clin Oncol 2010; 28:2300-2309
56. Mitry E, Fields ALA, Bleiberg H, et al: Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 2008;26:4906-1491
57. Lorenz M, Muller HH, Schramm H, et al: Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 1998;228:756-762
58. Kemeny MM, Adak S, Gray B, et al: Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J Clin Oncol 2002;20:1499-1505
59. Kemeny N, Huang Y, Cohen AM, et al: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341:2039-2048
60. Kemeny NE, Gonen M: Hepatic arterial infusion after liver resection. N Engl J Med 2005;352:734-735
61. Nelson RL, Freels S: Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver. Cochrane Database of Systematic Reviews. 2006:Art. No.:CD003770. DOI: 10.1002/14651858.CD003770. pub3
62. Van Cutsem E, Dicato M, Wils J, et al: Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001). Eur J Cancer 2002;38:1429-1436
63. De Haas RJ, Wicherts DA, Salloum C, et al: Long-term outcomes after hepatic resection for colorectal metastases in young patients. Cancer 2010;116:647-658
64. Morris EJA, Forman D, Thomas JD, et al: Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 2010;97:1110-1118
65. Langer B, Bleiberg H, Labianca R, et al: Fluorouracil (FU) plus l-leucovorin (l-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC): results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial. Proc Am Soc Clin Oncol 2002;21:A592
66. Portier G, Elias D, Bouche O, et al: Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 2006;24:4976-498